
    
      This single site study will be a clinical research data base of patients hospitalized and
      diagnosed with Clostridium difficile infection (CDI), treated with Fidaxomicin and willing to
      allow us to collect discard biological samples for testing and analysis in the investigators
      lab. An additional blood sample will be obtained if a clinically indicated bronchoscopy is
      performed as to measure the amount of medication in the BAL. We will also complete a medical
      record review will also occur.
    
  